Announcements Trials
Browse Landscape

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Other neoplasm 1

Conditions

Lung Neoplasms 4Neoplasms 2Small Cell Lung Carcinoma 1Recurrent respiratory papillomatosis 1Precancerous Conditions 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 61Carboplatin 44Pemetrexed 31Paclitaxel 31Docetaxel 31Cisplatin 27Gemcitabine 24Nivolumab 23Erlotinib Hydrochloride 21Bevacizumab 18Ipilimumab 11osimertinib 10Drug Therapy 10atezolizumab 9Radiosurgery 9Cyclophosphamide 9Cetuximab 9Blood Specimen Collection 9durvalumab 8cemiplimab 8Radiotherapy 8budigalimab 7Fluorouracil 7Dexamethasone 7trametinib 6fludarabine 6dostarlimab 6avelumab 6Taxes 6130-nm albumin-bound paclitaxel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Tomography, Optical Coherence × Thoracic × Clear all
NCT00733252 2015-10-02

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

Case Comprehensive Cancer Center

Withdrawn
Other neoplasmOther solid neoplasmThoracic

Recurrent respiratory papillomatosis, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Neoplasms, Precancerous Conditions, Small Cell Lung Carcinoma

NCT01039311 2013-02-01

OCT

University of Oklahoma

Terminated
16 enrolled
Thoracic

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡